ACCP "Excellence in Achievement"
The ACCP "Excellence in Achievement" Program serves to acknowledge ACCP Members whose engagement with ACCP events/committees and contributions to the organization are deserving of recognition.
ACCP is pleased to recognize Matthew W. Hruska, PharmD, PhD, Senior Director, Kyowa Kirin Pharmaceutical Development Inc (KKD), Clinical Pharmacology. Dr. Hruska joined ACCP in 2017 and has been actively involved in the society as a member of the ACCP Honors & Awards Committee and in supporting the society by submitting manuscripts to The Journal of Clinical Pharmacology and attending the Live ACCP Virtual Journal Club webinars.
Dr. Hruska received his PharmD and PhD in Pharmaceutical Sciences from the Univ of Pittsburgh. As Senior Director of Clinical Pharmacology at KKD, he is the Head of Clinical Pharmacology and provides development and oversight to the clinical pharmacology leads on programs across various therapeutic areas, including Oncology, Neuroscience, Nephrology and Immunoscience. Dr. Hruska also provides his expertise on cross-functional teams in early and late development, including Crysvita®and Poteligeo®. Prior to joining KKD, he was Director of Clinical Pharmacology & Pharmacometrics at Bristol-Myers Squibb where he was the clinical pharmacology lead and provided pharmacokinetic and pharmacodynamic expertise on cross-functional project teams in Immuno-Oncology early and late development. Dr. Hruska has been a presenter at national and international meetings, co-authored manuscripts and has been the recipient of select honors and awards.
Dr. Hruska graciously shared his thoughts on what ACCP membership means to him: “I joined ACCP a few years ago to expand my professional network and benefit from the educational opportunities offered, including virtual learning and the Annual Meeting Symposia and Poster Sessions. I have found that in addition to those aspects, ACCP provides many opportunities for Members to actively support the society. ACCP Members can give back to the clinical pharmacology community, while shaping the society in the present and the future. This past year, I took advantage of one of these opportunities by volunteering on the Honors & Awards Committee. It was a great way to see how ACCP Members collaborate together to recognize excellence within the clinical pharmacology community. Finally, I have found that the ACCP Annual Meeting is a great place to re-engage with old colleagues, meet new ones and increase one’s clinical pharmacology expertise. I look forward to continuing my active membership in ACCP and enjoying all of the benefits that ACCP offers.”
Congratulations, Dr. Hruska, on being recognized for your outstanding achievements and contributions to ACCP! Read more about Dr. Hruska in his CV.